Biotech Stocks Surge on Trump Victory (XBI) (IBB)

Biotech stocks are surging in pre-open trade on Trump Win. Trump is viewed as potentially less onerous than Clinton on drug pricing.

• XBI (NYSE: XBI) is up 5.6%
• IBB (NYSE: IBB) is up 6%
• Gilead Sciences (NASDAQ: GILD) +3.8%
• Celgene (NASDAQ: CELG) +4%
• Amgen (NASDAQ: AMGN) +5%
• Biogen (NASDAQ: BIIB) +4%

You May Also Be Interested In

• Electra Therapeutics files for proposed IPO
• Premarket movers: Nvidia in focus, Intuit slides and Semtech surges
• PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit